＜＜Back

Next＞＞

Vol. 29　Suppl. 1　2001

Opening Remarks

T. Namihisa

Jpn Pharmacol Ther 2001 29(s1) s3

---

Endothelin－1 supresses plasma membrane Ca⁺⁺－ATPase
in hepatic sinusoidal endothelial fenestrae in hepatic sinusoidal cells

H. Yokomori, et al.

Jpn Pharmacol Ther 2001 29(s1) s9

---

Direct evidence of NO production in rat hepatocytes and kupffer cells using a new fluorescent indicator：DAF－2 DA

T. Kono, et al.

Jpn Pharmacol Ther 2001 29(s1) s13

---

A study of nitric oxide levels in portal hypertensive disease accompanied with esophageal varices

H. Hidaka, et al.　

Jpn Pharmacol Ther 2001 29(s1) s17

---

【Discussion 1～3】　

Jpn Pharmacol Ther 2001 29(s1) s21

---

Renovascular resistance in patients with chronic liver diseases
―Assessment with color doppler ultrasonography―

M. Koda, et al.

Jpn Pharmacol Ther 2001 29(s1) s23

---

Cerebral vascular resistance assessed by transcranial doppler sonography in patients with chronic liver disease

M. Kawakami, et al.　

Jpn Pharmacol Ther 2001 29(s1) s29

---

Inhibitory effect of central corticotropin-releasing factor on hepatic blood flow

M. Yoneda, et al.

Jpn Pharmacol Ther 2001 29(s1) s37

---

The role of vascular endothelial growth factor（VEGF）on murine hepatocellular carcinoma tumor development with retrovirus mediated tetracycline－gene regulation system

H. Yoshiji, et al.

Jpn Pharmacol Ther 2001 29(s1) s41

---

Discussion【4～7】

Jpn Pharmacol Ther 2001 29(s1) s49

---

Effects of glycyrrhizin on the glucocorticoid signal transduction pathway in hepatocytes

T. Yoh, et al.

Jpn Pharmacol Ther 2001 29(s1) s53

---

CXC chemokine and polymorphonuclear leukocyte play a pivotal role in immunological liver injury in mice

K. Nakamura, et al.

Jpn Pharmacol Ther 2001 29(s1) s57

---

Dietary iron reduction in chronic hepatitis C patients

M. Iwasa, et al.

Jpn Pharmacol Ther 2001 29(s1) s63

---

Usefulness of the molar ratio of branched－chain amino acids to tyrosine（BTR）as a diagnosis tool for hepatic reserve dysfunction
―Correlation with asialo－scintigraphy―

C. Koreeda, et al.

Jpn Pharmacol Ther 2001 29(s1) s65

---

【Discussion 8～11】

Jpn Pharmacol Ther 2001 29(s1) s73

---

Gastrointestinal bleeding with liver cirrhosis and hyperbilirubinemia

S. Nishimura, et al.

Jpn Pharmacol Ther 2001 29(s1) s77

---

Direct and indirect influences of bilirubin on bile lithogenecity

K. Nakai, et al.　

Jpn Pharmacol Ther 2001 29(s1) s81

---

The new therapeutic strategy for unconjugated hyperbilirubinemia

T. Nishioka, et al.

Jpn Pharmacol Ther 2001 29(s1) s85

---

Mutations of bilirubin UDP－glucuronosyltranseferase gene（UGT1A1）in Japanese population

K. Takeuchi, et al.

Jpn Pharmacol Ther 2001 29(s1) s89

---

【Discussion 12～15】

Jpn Pharmacol Ther 2001 29(s1) s93

---

Effects of dexamethasone, PhG and PhS on biliary excretion of glutathion

T. Ogasawara, et al.

Jpn Pharmacol Ther 2001 29(s1) s97

---

Functional analysis of rat organic anion transporter 2（Oat2）

N. Morita, et al.

Jpn Pharmacol Ther 2001 29(s1) s101

---

Molecular mechanism of organic anion transport by rat mrp2 and mrp3

A. Morikawa, et al.　

Jpn Pharmacol Ther 2001 29(s1) s105

---

Kinetic analysis of efflux of bile acids across the sinusoidal membrane
―Comprasion between normal and mrp2－deficient rats―

H. Suzuki, et al.

Jpn Pharmacol Ther 2001 29(s1) s109

---

【Discussion 16～19】

Jpn Pharmacol Ther 2001 29(s1) s111

---

Correlation between hepatic and renal multidrug resistance－associated
protein 2 expression in bile duct－ligated rats

Y. Tanaka, et al.

Jpn Pharmacol Ther 2001 29(s1) s113

---

Distribution and intracellular localization of multidrug resistance－associated proteins 1（mrp1）and 2（mrp2）in rat liver and kidney after bile duct ligation

QL. Pei, et al.

Jpn Pharmacol Ther 2001 29(s1) s115

---

Analysis of the transpord mechanism of UDP－glucuronic acid into human liver microsomes

Y. Moriya, et al.

Jpn Pharmacol Ther 2001 29(s1) s119

---

ALDH2 and CYP2E1 genotypes　in hepatocellular carcinoma patients

K. Okamoto, et al.

Jpn Pharmacol Ther 2001 29(s1) s123

---

【Discussion 20～23】

Jpn Pharmacol Ther 2001 29(s1) s129

---

Molecular analysis of the function of hepatic constituent cells in the post－genomic era

N. Kawada

Jpn Pharmacol Ther 2001 29(s1) s131

---

Discussion　

Jpn Pharmacol Ther 2001 29(s1) s135

---

Closing Remarks

M. Inoue

Jpn Pharmacol Ther 2001 29(s1) s137